aluates Reports

$ 0.0

Automative

Global LFA-based Cardiac Market Research Report 2026

Published Date: 2026-02-26

Report Code: QYRE-Auto-32I9043

Global LFA based Cardiac Market Size Status and Forecast 2022

BUY CHAPTERS

Global LFA-based Cardiac Market Research Report 2026

Code: QYRE-Auto-32I9043

Report

2026-02-26

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Abbott

Danaher

Bio Rad Laboratories

bioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox Laboratories

Wondfo Biotech

Siemens AG

EasyDiagnosis Biomedicine

LFA-based Cardiac Market Size

The global LFA-based Cardiac market was valued at US$ 4478 million in 2025 and is anticipated to reach US$ 6523 million by 2032, at a CAGR of 5.6% from 2026 to 2032.

LFA-based Cardiac Market

Lateral flow cardiac markers are a rapid detection tool based on lateral flow immunochromatography technology, which is used to qualitatively or quantitatively detect specific cardiac biomarkers in the blood (such as troponin I/T, myoglobin, BNP, etc.). The principle is to form a visual detection line on the test strip through antigen-antibody reaction, so as to quickly judge abnormal cardiac function or myocardial damage. This technology has the advantages of convenience, rapidity (results in 15-30 minutes), low cost, and no need for complex equipment. It is widely used in emergency, primary care, home self-testing and other scenarios.

Market drivers:

Disease demand growth:

Cardiovascular disease is the world's leading cause of death, with a large and growing patient base. China has more than 330 million cardiovascular disease patients, and there is an urgent need for early screening and immediate diagnosis.

Acute myocardial infarction, heart failure and other acute diseases require rapid testing (such as the demand for troponin immediate testing in chest pain centers), and lateral flow technology can shorten the diagnosis time and improve prognosis.

Policy promotion:

Tiered diagnosis and treatment: Policies guide the sinking of high-quality medical resources, and primary medical institutions (such as community hospitals and township health centers) need to be equipped with POCT (point-of-care testing) equipment. Lateral flow cardiac markers are the first choice because of their simple operation and low cost.

Medical insurance coverage: Some cardiac marker tests are included in medical insurance, reducing the burden on patients and improving the accessibility of testing.

Technology iteration:

Sensitivity improvement: The application of nanomaterials (such as gold nanoparticles) improves detection sensitivity and can detect low-concentration markers (such as high-sensitivity troponin).

Multi-indicator joint detection: The same test strip realizes the joint detection of multiple markers (such as troponin + BNP + D-dimer), improving diagnostic efficiency.

Intelligence: Combined with mobile phone APP or portable reader, the results can be automatically transmitted and interpreted to reduce human errors.

Application scenario expansion:

Pre-hospital emergency: rapid screening at ambulance and emergency scene, auxiliary decision-making (such as whether to transfer directly to the catheterization room).

Home monitoring: patients with chronic heart failure can self-test BNP at home and adjust drug dosage in time.

Physical examination screening: early cardiac function assessment for high-risk groups (such as patients with hypertension and diabetes).

Market trend:

Domestic substitution: domestic companies (such as Wondfo Biotech and Mindray Biotech) have made technological breakthroughs, breaking the import monopoly and reducing costs.

Standardized development: industry standards are gradually improved, promoting the transformation of product homogeneity to differentiated competition (such as specific marker detection and personalized services).

The lateral flow cardiac marker market is driven by disease demand, policy promotion, and technological upgrading. In the future, it will continue to develop in the direction of rapidity, multi-indicators, and intelligence, and become an important tool for the diagnosis and treatment of cardiovascular diseases.

This report delivers a comprehensive overview of the global LFA-based Cardiac market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding LFA-based Cardiac. The LFA-based Cardiac market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global LFA-based Cardiac market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist LFA-based Cardiac manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of LFA-based Cardiac Market Report

Report Metric	Details
Report Name	LFA-based Cardiac Market
Accounted market size in 2025	US$ 4478 million
Forecasted market size in 2032	US$ 6523 million
CAGR	5.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Troponin I Troponin T CK-MB Myoglobin Others
Segment by Application	Laboratory Testing Point-of-care Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, Wondfo Biotech, EasyDiagnosis Biomedicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for LFA-based Cardiac companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is LFA-based Cardiac Market growing?

Ans: The LFA-based Cardiac Market witnessing a CAGR of 5.6% during the forecast period 2026-2032.

What is the LFA-based Cardiac Market size in 2032?

Ans: The LFA-based Cardiac Market size in 2032 will be US$ 6523 million.

Who are the main players in the LFA-based Cardiac Market report?

Ans: The main players in the LFA-based Cardiac Market are Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, Wondfo Biotech, EasyDiagnosis Biomedicine

What are the Application segmentation covered in the LFA-based Cardiac Market report?

Ans: The Applications covered in the LFA-based Cardiac Market report are Laboratory Testing, Point-of-care Testing

What are the Type segmentation covered in the LFA-based Cardiac Market report?

Ans: The Types covered in the LFA-based Cardiac Market report are Troponin I, Troponin T, CK-MB, Myoglobin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Troponin I

1.2.3 Troponin T

1.2.4 CK-MB

1.2.5 Myoglobin

1.2.6 Others

1.3 Market by Application

1.3.1 Global LFA-based Cardiac Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Laboratory Testing

1.3.3 Point-of-care Testing

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global LFA-based Cardiac Market Perspective (2021–2032)

2.2 Global LFA-based Cardiac Growth Trends by Region

2.2.1 Global LFA-based Cardiac Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 LFA-based Cardiac Historic Market Size by Region (2021–2026)

2.2.3 LFA-based Cardiac Forecasted Market Size by Region (2027–2032)

2.3 LFA-based Cardiac Market Dynamics

2.3.1 LFA-based Cardiac Industry Trends

2.3.2 LFA-based Cardiac Market Drivers

2.3.3 LFA-based Cardiac Market Challenges

2.3.4 LFA-based Cardiac Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top LFA-based Cardiac Players by Revenue

3.1.1 Global Top LFA-based Cardiac Players by Revenue (2021–2026)

3.1.2 Global LFA-based Cardiac Revenue Market Share by Players (2021–2026)

3.2 Global Top LFA-based Cardiac Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by LFA-based Cardiac Revenue

3.4 Global LFA-based Cardiac Market Concentration Ratio

3.4.1 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Revenue in 2025

3.5 Global Key Players of LFA-based Cardiac Head Offices and Areas Served

3.6 Global Key Players of LFA-based Cardiac, Products and Applications

3.7 Global Key Players of LFA-based Cardiac, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 LFA-based Cardiac Breakdown Data by Type

4.1 Global LFA-based Cardiac Historic Market Size by Type (2021–2026)

4.2 Global LFA-based Cardiac Forecasted Market Size by Type (2027–2032)

5 LFA-based Cardiac Breakdown Data by Application

5.1 Global LFA-based Cardiac Historic Market Size by Application (2021–2026)

5.2 Global LFA-based Cardiac Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America LFA-based Cardiac Market Size (2021–2032)

6.2 North America LFA-based Cardiac Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America LFA-based Cardiac Market Size by Country (2021–2026)

6.4 North America LFA-based Cardiac Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe LFA-based Cardiac Market Size (2021–2032)

7.2 Europe LFA-based Cardiac Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe LFA-based Cardiac Market Size by Country (2021–2026)

7.4 Europe LFA-based Cardiac Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific LFA-based Cardiac Market Size (2021–2032)

8.2 Asia-Pacific LFA-based Cardiac Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific LFA-based Cardiac Market Size by Region (2021–2026)

8.4 Asia-Pacific LFA-based Cardiac Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America LFA-based Cardiac Market Size (2021–2032)

9.2 Latin America LFA-based Cardiac Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America LFA-based Cardiac Market Size by Country (2021–2026)

9.4 Latin America LFA-based Cardiac Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa LFA-based Cardiac Market Size (2021–2032)

10.2 Middle East & Africa LFA-based Cardiac Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa LFA-based Cardiac Market Size by Country (2021–2026)

10.4 Middle East & Africa LFA-based Cardiac Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche LFA-based Cardiac Introduction

11.1.4 Roche Revenue in LFA-based Cardiac Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott LFA-based Cardiac Introduction

11.2.4 Abbott Revenue in LFA-based Cardiac Business (2021–2026)

11.2.5 Abbott Recent Development

11.3 Siemens

11.3.1 Siemens Company Details

11.3.2 Siemens Business Overview

11.3.3 Siemens LFA-based Cardiac Introduction

11.3.4 Siemens Revenue in LFA-based Cardiac Business (2021–2026)

11.3.5 Siemens Recent Development

11.4 Danaher

11.4.1 Danaher Company Details

11.4.2 Danaher Business Overview

11.4.3 Danaher LFA-based Cardiac Introduction

11.4.4 Danaher Revenue in LFA-based Cardiac Business (2021–2026)

11.4.5 Danaher Recent Development

11.5 Bio-Rad Laboratories

11.5.1 Bio-Rad Laboratories Company Details

11.5.2 Bio-Rad Laboratories Business Overview

11.5.3 Bio-Rad Laboratories LFA-based Cardiac Introduction

11.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2021–2026)

11.5.5 Bio-Rad Laboratories Recent Development

11.6 BioMérieux

11.6.1 BioMérieux Company Details

11.6.2 BioMérieux Business Overview

11.6.3 BioMérieux LFA-based Cardiac Introduction

11.6.4 BioMérieux Revenue in LFA-based Cardiac Business (2021–2026)

11.6.5 BioMérieux Recent Development

11.7 Thermo Fisher

11.7.1 Thermo Fisher Company Details

11.7.2 Thermo Fisher Business Overview

11.7.3 Thermo Fisher LFA-based Cardiac Introduction

11.7.4 Thermo Fisher Revenue in LFA-based Cardiac Business (2021–2026)

11.7.5 Thermo Fisher Recent Development

11.8 Ortho Clinical Diagnostics

11.8.1 Ortho Clinical Diagnostics Company Details

11.8.2 Ortho Clinical Diagnostics Business Overview

11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Introduction

11.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2021–2026)

11.8.5 Ortho Clinical Diagnostics Recent Development

11.9 LSI Medience Corporation

11.9.1 LSI Medience Corporation Company Details

11.9.2 LSI Medience Corporation Business Overview

11.9.3 LSI Medience Corporation LFA-based Cardiac Introduction

11.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Business (2021–2026)

11.9.5 LSI Medience Corporation Recent Development

11.10 Randox laboratories

11.10.1 Randox laboratories Company Details

11.10.2 Randox laboratories Business Overview

11.10.3 Randox laboratories LFA-based Cardiac Introduction

11.10.4 Randox laboratories Revenue in LFA-based Cardiac Business (2021–2026)

11.10.5 Randox laboratories Recent Development

11.11 Wondfo Biotech

11.11.1 Wondfo Biotech Company Details

11.11.2 Wondfo Biotech Business Overview

11.11.3 Wondfo Biotech LFA-based Cardiac Introduction

11.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Business (2021–2026)

11.11.5 Wondfo Biotech Recent Development

11.12 EasyDiagnosis Biomedicine

11.12.1 EasyDiagnosis Biomedicine Company Details

11.12.2 EasyDiagnosis Biomedicine Business Overview

11.12.3 EasyDiagnosis Biomedicine LFA-based Cardiac Introduction

11.12.4 EasyDiagnosis Biomedicine Revenue in LFA-based Cardiac Business (2021–2026)

11.12.5 EasyDiagnosis Biomedicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Abbott

Danaher

Bio Rad Laboratories

bioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox Laboratories

Wondfo Biotech

Siemens AG

EasyDiagnosis Biomedicine

List of Tables

Table 1. Global LFA-based Cardiac Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Troponin I

Table 3. Key Players of Troponin T

Table 4. Key Players of CK-MB

Table 5. Key Players of Myoglobin

Table 6. Key Players of Others

Table 7. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global LFA-based Cardiac Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global LFA-based Cardiac Market Size by Region (US$ Million), 2021–2026

Table 10. Global LFA-based Cardiac Market Share by Region (2021–2026)

Table 11. Global LFA-based Cardiac Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global LFA-based Cardiac Market Share by Region (2027–2032)

Table 13. LFA-based Cardiac Market Trends

Table 14. LFA-based Cardiac Market Drivers

Table 15. LFA-based Cardiac Market Challenges

Table 16. LFA-based Cardiac Market Restraints

Table 17. Global LFA-based Cardiac Revenue by Players (US$ Million), 2021–2026

Table 18. Global LFA-based Cardiac Market Share by Players (2021–2026)

Table 19. Global Top LFA-based Cardiac Players by Tier (Tier 1, Tier 2, and Tier 3), based on LFA-based Cardiac Revenue, 2025

Table 20. Ranking of Global Top LFA-based Cardiac Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by LFA-based Cardiac Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of LFA-based Cardiac, Headquarters and Area Served

Table 23. Global Key Players of LFA-based Cardiac, Products and Applications

Table 24. Global Key Players of LFA-based Cardiac, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global LFA-based Cardiac Market Size by Type (US$ Million), 2021–2026

Table 27. Global LFA-based Cardiac Revenue Market Share by Type (2021–2026)

Table 28. Global LFA-based Cardiac Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global LFA-based Cardiac Revenue Market Share by Type (2027–2032)

Table 30. Global LFA-based Cardiac Market Size by Application (US$ Million), 2021–2026

Table 31. Global LFA-based Cardiac Revenue Market Share by Application (2021–2026)

Table 32. Global LFA-based Cardiac Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global LFA-based Cardiac Revenue Market Share by Application (2027–2032)

Table 34. North America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America LFA-based Cardiac Market Size by Country (US$ Million), 2021–2026

Table 36. North America LFA-based Cardiac Market Size by Country (US$ Million), 2027–2032

Table 37. Europe LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe LFA-based Cardiac Market Size by Country (US$ Million), 2021–2026

Table 39. Europe LFA-based Cardiac Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific LFA-based Cardiac Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific LFA-based Cardiac Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific LFA-based Cardiac Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America LFA-based Cardiac Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America LFA-based Cardiac Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa LFA-based Cardiac Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa LFA-based Cardiac Market Size by Country (US$ Million), 2027–2032

Table 49. Roche Company Details

Table 50. Roche Business Overview

Table 51. Roche LFA-based Cardiac Product

Table 52. Roche Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 53. Roche Recent Development

Table 54. Abbott Company Details

Table 55. Abbott Business Overview

Table 56. Abbott LFA-based Cardiac Product

Table 57. Abbott Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 58. Abbott Recent Development

Table 59. Siemens Company Details

Table 60. Siemens Business Overview

Table 61. Siemens LFA-based Cardiac Product

Table 62. Siemens Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 63. Siemens Recent Development

Table 64. Danaher Company Details

Table 65. Danaher Business Overview

Table 66. Danaher LFA-based Cardiac Product

Table 67. Danaher Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 68. Danaher Recent Development

Table 69. Bio-Rad Laboratories Company Details

Table 70. Bio-Rad Laboratories Business Overview

Table 71. Bio-Rad Laboratories LFA-based Cardiac Product

Table 72. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 73. Bio-Rad Laboratories Recent Development

Table 74. BioMérieux Company Details

Table 75. BioMérieux Business Overview

Table 76. BioMérieux LFA-based Cardiac Product

Table 77. BioMérieux Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 78. BioMérieux Recent Development

Table 79. Thermo Fisher Company Details

Table 80. Thermo Fisher Business Overview

Table 81. Thermo Fisher LFA-based Cardiac Product

Table 82. Thermo Fisher Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 83. Thermo Fisher Recent Development

Table 84. Ortho Clinical Diagnostics Company Details

Table 85. Ortho Clinical Diagnostics Business Overview

Table 86. Ortho Clinical Diagnostics LFA-based Cardiac Product

Table 87. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 88. Ortho Clinical Diagnostics Recent Development

Table 89. LSI Medience Corporation Company Details

Table 90. LSI Medience Corporation Business Overview

Table 91. LSI Medience Corporation LFA-based Cardiac Product

Table 92. LSI Medience Corporation Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 93. LSI Medience Corporation Recent Development

Table 94. Randox laboratories Company Details

Table 95. Randox laboratories Business Overview

Table 96. Randox laboratories LFA-based Cardiac Product

Table 97. Randox laboratories Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 98. Randox laboratories Recent Development

Table 99. Wondfo Biotech Company Details

Table 100. Wondfo Biotech Business Overview

Table 101. Wondfo Biotech LFA-based Cardiac Product

Table 102. Wondfo Biotech Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 103. Wondfo Biotech Recent Development

Table 104. EasyDiagnosis Biomedicine Company Details

Table 105. EasyDiagnosis Biomedicine Business Overview

Table 106. EasyDiagnosis Biomedicine LFA-based Cardiac Product

Table 107. EasyDiagnosis Biomedicine Revenue in LFA-based Cardiac Business (US$ Million), 2021–2026

Table 108. EasyDiagnosis Biomedicine Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. LFA-based Cardiac Picture

Figure 2. Global LFA-based Cardiac Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global LFA-based Cardiac Market Share by Type: 2025 vs 2032

Figure 4. Troponin I Features

Figure 5. Troponin T Features

Figure 6. CK-MB Features

Figure 7. Myoglobin Features

Figure 8. Others Features

Figure 9. Global LFA-based Cardiac Market Size by Application (US$ Million), 2021–2032

Figure 10. Global LFA-based Cardiac Market Share by Application: 2025 vs 2032

Figure 11. Laboratory Testing Case Studies

Figure 12. Point-of-care Testing Case Studies

Figure 13. LFA-based Cardiac Report Years Considered

Figure 14. Global LFA-based Cardiac Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global LFA-based Cardiac Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global LFA-based Cardiac Market Share by Region: 2025 vs 2032

Figure 17. Global LFA-based Cardiac Market Share by Players in 2025

Figure 18. Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by LFA-based Cardiac Revenue in 2025

Figure 20. North America LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America LFA-based Cardiac Market Share by Country (2021–2032)

Figure 22. United States LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe LFA-based Cardiac Market Share by Country (2021–2032)

Figure 26. Germany LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific LFA-based Cardiac Market Share by Region (2021–2032)

Figure 34. China LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America LFA-based Cardiac Market Share by Country (2021–2032)

Figure 42. Mexico LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa LFA-based Cardiac Market Share by Country (2021–2032)

Figure 46. Israel LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE LFA-based Cardiac Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Roche Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 50. Abbott Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 51. Siemens Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 52. Danaher Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 53. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 54. BioMérieux Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 55. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 56. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 57. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 58. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 59. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 60. EasyDiagnosis Biomedicine Revenue Growth Rate in LFA-based Cardiac Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Medical Lateral Flow Assay LFA Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

LFA based Rapid Testing Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lateral Flow Test and Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Food Lateral Flow Assay LFA Testing Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Cardiac Reader Systems Market Research Report 2024

Global Cardiac Marker Analyzer Market Research Report 2025

Global Clinical Cardiac Marker Analyzer Market Research Report 2024

Cardiac Markers Testing Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lateral Flow Assay LFA Components Market Research Report 2024

Global POC Cardiac Marker Analyzer Market Research Report 2024

Cardiac Marker POC Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lateral Flow Assay Reader Market Research Report 2024

Global Lateral Flow Assay Cassettes Market Research Report 2024

Global Lateral Flow Immunoassay Membrane Market Research Report 2024

Global ST2 Biomarker Market Research Report 2024

Global Handheld Lateral Flow Readers Market Research Report 2024

Global Diagnostic Biomarker Market Research Report 2024

Lateral Flow Immunoassay Kit for Food Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiac Marker Testing Kits Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions